National Bank of Canada’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
National Bank of Canada's AMGN Position: Q1 2026 in Review
National Bank of Canada reduced its Amgen (AMGN) stake by 38% in Q1 2026, selling an estimated $90.9M and leaving 420,993 shares worth $148M. The position accounts for 0.13% of the portfolio, ranked #135.
National Bank of Canada first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $346M in Q3 2025. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- National Bank of Canada held 420,993 shares of Amgen worth $148M as of Q1 2026.
- National Bank of Canada sold 254,963 Amgen shares in Q1 2026, an estimated $90.9M.
- Amgen made up 0.13% of National Bank of Canada's portfolio in Q1 2026, its #135 holding.
- National Bank of Canada first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
- National Bank of Canada's Amgen position peaked at $346M in Q3 2025.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.